In a filing, Palvella Therapeutics Inc revealed its Director JENKINS GEORGE M acquired Company’s shares for reported $50472.0 on Apr 09 ’25. In the deal valued at $20.27 per share,2,490 shares were bought. As a result of this transaction, JENKINS GEORGE M now holds 13,516 shares worth roughly $0.49 million.
Then, JENKINS GEORGE M bought 2,500 shares, generating $50,325 in total proceeds. Upon buying the shares at $20.13, the Director now owns 183,171 shares.
Before that, JENKINS GEORGE M bought 4,000 shares. Palvella Therapeutics Inc shares valued at $51,720 were divested by the Director at a price of $12.93 per share. As a result of the transaction, JENKINS GEORGE M now holds 180,671 shares, worth roughly $6.5 million.
Truist initiated its Palvella Therapeutics Inc [PVLA] rating to a Buy in a research note published on July 21, 2025; the price target was $56. A number of analysts have revised their coverage, including Chardan Capital Markets’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. Stifel began covering PVLA with “Buy” recommendation on March 26, 2025. Scotiabank started covering the stock on March 07, 2025. It rated PVLA as “a Sector outperform”.
Price Performance Review of PVLA
On Tuesday, Palvella Therapeutics Inc [NASDAQ:PVLA] saw its stock jump 16.13% to $36.0. Over the last five days, the stock has gained 29.96%. Palvella Therapeutics Inc shares have risen nearly 368.14% since the year began. Nevertheless, the stocks have risen 200.00% over the past one year. While a 52-week high of $31.50 was reached on 07/22/25, a 52-week low of $7.30 was recorded on 01/02/25.
Levels Of Support And Resistance For PVLA Stock
The 24-hour chart illustrates a support level at 32.60, which if violated will result in even more drops to 29.21. On the upside, there is a resistance level at 37.80. A further resistance level may holdings at 39.60.
How much short interest is there in Palvella Therapeutics Inc?
A steep rise in short interest was recorded in Palvella Therapeutics Inc stocks on 2025-06-30, growing by 0.3 million shares to a total of 0.57 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-30 was 0.27 million shares. There was a rise of 52.48%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 20, 2025 when Canaccord Genuity began covering the stock and recommended ‘”a Buy”‘ rating along with a $39 price target.
